Although the underlying mechanisms remain unclear, some DM-specific vascular pathological factors, such as advanced glycosylated end products, insulin resistance, and reactive oxygen species, may interplay in the complex pathogenesis of CKD–MBD and act synergistically with FGF23 on changing vascular wall structure. This evidence concerns the gene INS and Marchiafava-Bignami disease.